The safety of plasma-derived products in Australia

Andrew Guirguis, Erica Wood

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)


Plasma-derived products are used in Australia in a wide variety of clinical settings. The majority of these products are manufactured locally from voluntary blood donations. The preparation of plasma products is subject to rigorous safety measures, including screening blood donors, testing plasma for infectious material, and subjecting plasma to dedicated pathogen inactivation steps. The safe use of plasma derivatives requires correct storage and handling.

Original languageEnglish
Pages (from-to)76-79
Number of pages4
JournalAustralian Prescriber
Issue number3
Publication statusPublished - Jun 2010
Externally publishedYes


  • Coagulation
  • Intravenous immunoglobulin
  • Pathogen inactivation

Cite this